Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
Standard
Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? / Hennigs, Jan K.; von Amsberg, Gunhild; Baumann, Hans Jörg; Honecker, Friedemann; Kluge, Stefan; Bokemeyer, Carsten; Brümmendorf, Tim; Klose, Hans.
in: BMC PULM MED, Jahrgang 11, 2011, S. 30.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
AU - Hennigs, Jan K.
AU - von Amsberg, Gunhild
AU - Baumann, Hans Jörg
AU - Honecker, Friedemann
AU - Kluge, Stefan
AU - Bokemeyer, Carsten
AU - Brümmendorf, Tim
AU - Klose, Hans
PY - 2011
Y1 - 2011
N2 - Pulmonary hypertension (PH) is a life-threatening disease with poor prognosis. Encouraging efforts have been made to target the main vasoproliferative aspects of the disease. Promising emerging therapeutics are tyrosine kinase inhibitors such as imatinib.
AB - Pulmonary hypertension (PH) is a life-threatening disease with poor prognosis. Encouraging efforts have been made to target the main vasoproliferative aspects of the disease. Promising emerging therapeutics are tyrosine kinase inhibitors such as imatinib.
KW - Humans
KW - Male
KW - Aged
KW - Treatment Outcome
KW - Hypertension, Pulmonary/chemically induced/diagnosis
KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
KW - Protein Kinase Inhibitors/adverse effects/therapeutic use
KW - Protein-Tyrosine Kinases/antagonists & inhibitors
KW - Pyrimidines/adverse effects/therapeutic use
KW - Thiazoles/adverse effects/therapeutic use
KW - Humans
KW - Male
KW - Aged
KW - Treatment Outcome
KW - Hypertension, Pulmonary/chemically induced/diagnosis
KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
KW - Protein Kinase Inhibitors/adverse effects/therapeutic use
KW - Protein-Tyrosine Kinases/antagonists & inhibitors
KW - Pyrimidines/adverse effects/therapeutic use
KW - Thiazoles/adverse effects/therapeutic use
U2 - 10.1186/1471-2466-11-30
DO - 10.1186/1471-2466-11-30
M3 - SCORING: Journal article
VL - 11
SP - 30
JO - BMC PULM MED
JF - BMC PULM MED
SN - 1471-2466
ER -